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INTRODUCTION 
           
         Securing the airway during conduction of general anaesthesia is one of the most 
important jobs of the anaesthesiologist. Ventilation during anaesthesia was managed 
without specialized airway devices for more than 50 years after Morton's discovery. 
Friedrich Von Esmarch described the jaw thrust as a lifesaving maneuver in some 
cases of airway obstruction that resulted from chloroform or asphyxia. The 
development of the modern facemask originated with Francis Sibson who devised a 
mask made of pliable tinned iron covered with glove leather. The mask covered the 
mouth and nose and therefore eliminated the need for nose clips.1 
  
          In the 18th century, tubes were passed into the trachea during resuscitation 
from drowning, but these tubes were passed without direct visualization and were not 
meant for the delivery of anaesthetic agents. Sir William Macewen was the first 
physician to intubate the trachea orally for the sole purpose of administering 
anaesthesia. Robert R. Macintosh's improved laryngoscope featured a short, curved 
blade that elevated instead of retracting the epiglottis, a considerable improvement 
over previous laryngoscopes2. Laryngoscopy and endotracheal intubation is a 
common method of securing the airway. However intubation is associated with 
tachycardia and hypertension, which is transient. A change in plasma catecholamine 
concentrations also has been seen3. Transitory hypertension and tachycardia are 
probably of no consequence in healthy individuals but either or both may be 
hazardous to those with hypertension, myocardial insufficiency or cerebrovascular 
diseases.4  
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          In the year 1983, Dr.Archie Brain described a new type of airway, which may 
be used as an alternative to the endotracheal tube or the facemask with either 
spontaneous or positive pressure ventilation. This was the Laryngeal Mask Airway 
(LMA). It was introduced into clinical practice in 1988. Since its introduction it has 
undergone many modifications and addition of various new models5. The wide 
variety of airway devices available today may broadly be classified as cuffed 
perilaryngeal sealers, and cuffless anatomically pre shaped sealers based on their 
sealing mechanisms6. As time went on, additional devices were added to the LMA 
family to satisfy specific needs and a number of other devices were developed. There 
are a large number of supraglottic airway devices, some of which appear similar to 
the LMA family and others that work under a different concept7. Originally intended 
as an alternative to mask ventilation, the supraglottic airway devices avoid many 
problems associated with intubation8,9. The popularity of the device for routine use 
stems from its perceived benefits to the patient and anaesthetist over traditional 
forms of airway management10.  
  
 Laryngeal mask airway is a supraglottic airway device with an inflatable cuff 
forming a low pressure seal around the laryngeal inlet and permitting ventilation. The 
primary limitation of the laryngeal mask airway (LMA) is that it does not reliably 
protect the lungs from regurgitated stomach contents, although it may act as a barrier 
at the level of the upper esophageal sphincter if it is correctly positioned. The 
incidence of aspiration with the LMA has been estimated at 0.02%, which is similar 
to tracheal intubation in elective patients.11 
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        Proseal laryngeal mask airway, a supraglottic airway device with an inflatable 
cuff and gastric drain tube has been widely used in paediatric and adult patients 
under both controlled and spontaneous ventilation12,13,14.The I-gel is a relatively 
newer and unique single use supraglottic airway device with non-inflatable cuff that 
snugly fits onto the perilaryngeal framework and has a gastric drain tube15,16. I-gel 
has been successfully used in both spontaneous and controlled ventilation.17,18 
  
In view of this, the present study was undertaken in Thanjavur medical 
college, Thanjavur  to compare the performance of two supraglottic airway devices,  
I-gel and proseal laryngeal mask airway (LMA) in relation to the time taken for 
insertion, number of attempts taken to insert the device, airway sealing pressure, ease 
of gastric tube placement, hemodynamic changes after insertion and post-operative 
complications in patients posted for puerperal/laparoscopic sterilisation under 
general anaesthesia. 
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AIM AND OBJECTIVES OF THE STUDY 
 
AIM OF THE STUDY: 
To study and compare I-gel and proseal laryngeal mask airway as a 
supraglottic airway device in patients undergoing elective surgeries. 
 
PRIMARY OBJECTIVE: 
To compare  1. The time taken for insertion. 
          2. Number of attempts taken to insert the device. 
          3. Airway sealing pressure. 
                     4. Ease of gastric tube placement. 
          5. Hemodynamic changes after insertion. 
 
SECONDARY OBJECTIVE: 
To compare - Adverse effects such as post extubation cough,laryngospasm, 
nausea/vomiting, trauma to lip/teeth/pharynx and post operative 
sore throat. 
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REVIEW OF LITERATURE 
Goyal R et al  had done a prospective randomized study, published in 2011, in 120 
children who underwent elective surgery of less than one hour duration, comparing 
size 2 Classic LMA, P-LMA and I-gel. This study was conducted at the Armed 
Forces Medical College, involved children of age two to five years, without 
anticipated  airway difficulties and ASA I and II.The insertion ease and oro-
pharyngeal sealing pressure had been compared. The authors had found that I-gel 
insertion was easy and the oro-pharyngeal sealing pressure was also found to be 
higher than the other two devices. The oro-pharyngeal sealing pressure of  I-gel was 
found to be (26 ± 2.6 cm H2O) as compared to that of P-LMA (23 ± 1.2cm H2O) and 
Classic LMA (22± 2.3 cm H2O) which was statistically significant. The authors 
concluded that I-gel could be used as a safe alternative to the LMA for day care 
surgeries.13 
Levitan RM et al published a study in 2005, that studied the positioning and 
mechanics of I-gel, an anatomically designed mask made of gel like thermoplastic 
elastomer, without an inflatable cuff. They found the mean percentage of glottis 
opening score for 73 insertions was 82% (95% confidence interval 75-89%). They 
found that I-gel effectively conformed to perilaryngeal anatomy and consistently 
achieved  proper  positioning for supraglottic ventilation.15 
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Sai S et al compared the efficacy of I-gel with P-LMA in paediatric patients under 
general anesthesia with controlled ventilation. A total of 60 patients of ASA I, II 
were included. Insertion parameters, ease of gastric tube insertion, fiberoptic scoring 
of glottis, airway parameters (EtCO2 and airway pressures),complications in first 12 
hours postoperatively were noted. They found both groups were comparable in all 
the parameters. There were no significant complications in first 12 hours. They 
concluded that I-gel was effective as P-LMA in paediatric patients under controlled 
ventilation.19 
Gurudas K et al compared I-gel with P-LMA in 48 adults of ASA I, II between age 
18 and 60 years, undergoing elective surgery under general anesthesia without 
paralysis. They compared time taken for insertion, effective seal, fiberoptic view of 
larynx, ease of ryle’s tube insertion and postoperative sore throat. They found lesser 
insertion time with I-gel (21.98± 5.42 secs) compared to P-LMA (30.60 ± 8.51 secs). 
The number of insertion attempts, fiberoptic view, and ease of ryle’s tube insertion 
and incidence of complication were comparable.20 
Anjan D et al had compared I-gel with P-LMA in 60 adult ASA I, II between age 20 
and 30 yrs of either sex. They compared the hemodynamic alterations in heart rate 
and blood pressure caused by the stress response by the devices. They found I-gel 
was more easy to insert (90% vs. 83.33%) and insertion time was shorter (14.9 vs. 20 
secs) compared to P-LMA. They also found hemodynamics was lesser altered with I- 
gel than P-LMA, which were statistically significant.21 
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  Gaurav C et al had compared I-gel with P-LMA in 80 adult ASAI, II between age 
18 and 65 yrs of either sex. Insertion parameters, ease of gastric tube insertion, fiber-
optic assessment, airway sealing pressures, and other complications were compared. 
They found mean insertion time less in I-gel (11.12± 1.814 secs) compared to P-
LMA (15.13 ± 2.91 secs). The mean airway sealing pressure in the P-LMA group 
(29.55 ± 3.53 cms H2O) was significantly higher than in the I-gel group (26.73 ± 
2.52  cm H2O). Also gastric tube insertion was easier in I-gel (p =0.001). 
Complications were less with I-gel compared to P-LMA.22 
Shi YB et al compared the efficacy of LMA supreme, proseal LMA and I-gel in 
patients undergoing laparoscopic surgery and found airway sealing pressure were 
higher in P-LMA and I-gel compared to supreme LMA. They also stated that I gel 
provided adequate ventilation during surgery with lesser complications.23 
Hayashi K et al compared single use I-gel with reusable P-LMA in spontaneously 
breathing adult patients. They found I-gel had faster insertion time (4.4 vs.16 secs, P 
<0.01) and did not require finger insertion with the device. Leak pressure was found 
to be similar in both the groups.24 
Gasteiger L et al had compared size 2 P-LMA and I-gel in a randomized crossover 
study published in 2012. This study was conducted in 51 children who were not 
paralysed but maintained with Remifentanyl, Propofol mixture and ventilated. The 
children were between 1.5 and 6 years of age and weighed 10 to 25 kg.  The oro-
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pharyngeal sealing pressures were 22 cmH2O for P-LMA and 21cmH2O for I-gel. 
The authors reported similar oro-pharyngeal sealing pressure and fibreoptic view for 
both devices.25 
Subro M et al had conducted a study, published in 2012, comparing I-gel and P-
LMA of 2.5 sizes in children. The 60 subjects were paralysed and undergoing 
elective surgery under ASA I, II. The authors had found demographic data, insertion 
ease, hemodynamics and complications to be comparable. This randomized, 
prospective study reports a higher airway-leak pressure for I-gel(27.12±1.69 cmH2O) 
which was statistically significant when compared to that of P-LMA (22.75±1.46) 
cm H2O, concluding that the oro-pharyngeal sealing pressure is the only parameter 
higher in I-gel.26 
Van Zundert TC et al had studied I-gel, P-LMA and LMA supreme in 150 patients, 
belonging to ASA I and II, between the ages of 18 to 60 years. This study was 
published in 2012. A laryngoscope guided, gastric tube guided technique had been 
used by the authors for insertion of the devices studied. They had reported easier and 
shorter time requirement for insertion of both P-LMA and I-gel. The anatomical 
positioning was found to be better with LMA supreme. The authors reported similar 
oro-pharyngeal sealing pressures with all the three devices in both apnoeic and 
spontaneously breathing conditions.27 
Woo JJ et al had published in 2012, a study conducted in 30 adult patients 
undergoing laparoscopic gynaecological surgeries; prospectively, randomly assigned 
to two groups P-LMA and I-gel. The time taken for insertion and the number of 
attempts required were compared along with measurement of airway-leak pressure. 
9 | P a g e  
 
The airway-leak pressures measured 10 minutes after insertion are reported to be 
(25.9 ± 5.2 cmH2O) for P-LMA and (24.3 ± 3.4 cmH2O) for I-gel. After 15 minutes 
of CO2 insufflation, the airway-leak pressures were (28.3 ± 5.9) cmH2O and (28.5 ± 
5.4) cmH2O, respectively. There was no statistically significant difference between 
the two devices regarding the above mentioned parameters.28 
Amr M et al  in a study published in 2010,  had compared I-gel and Classic LMA in 
80 non paralysed patients of age 21 to 60 years,body mass index 20-25kg/m2,  
undergoing surgeries in supine position for not more than two hours. In this 
prospective randomized trial, the authors had studied the duration and number of 
attempts of insertion, gastric insufflations incidence, leak pressure and assessment of 
the airway after removing the device. A significantly short duration taken for 
insertion of I-gel (15.6 ± 17.7 seconds) as opposed to that of classic  LMA (26.2 ± 
17.7 seconds) has been reported. Leak pressure was (25.6 ± 4.9 cm H2O) vs.  (21.2 ± 
7.7 cm H2O ) significantly higher in I-gel (P=0.016) and incidence of gastric 
insufflation was significantly more with classic LMA (22.5%) as compared to I-gel 
(5%) (P=0.016). All other parameters compared were similar.29 
Gasteiger L et al in 2010 published a randomized, non-crossover study in 152 
female patients between 18 and 70 years. They tested the ease of insertion using a 
duodenal tube guided insertion and the oro-pharyngeal leak pressure between          
P-LMA and I-gel. They found overall insertion rate, mean insertion attempts were 
similar in both the groups. Mean oro-pharyngeal leak pressure was higher in P-LMA 
group. They concluded that insertion of both the devices were similarly easy using a 
guided technique and P-LMA forms an effective seal for ventilation.30 
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Singh I et al had published a study in 2009. They had compared P-LMA and I-gel in 
a population of 60 ASA I, II adult patients undergoing elective surgery. In this 
prospective randomized study airway-leak pressure,ease of insertion, ease of 
insertion of orogastric tube and complications like trauma to the airway-lips, teeth 
and blood staining after removal were noted. The airway-leak pressure for I-gel was 
a mean of 25.27 cm H2O and that with PLMA was a mean of 29.6 cm H2O. The 
airway sealing pressure of I-gel was very well within normal limits to prevent 
aspiration. The ease of' insertion was more with I-gel (29/30) than with P-LMA 
(23/30). Whereas, incidence of airway trauma and blood staining were not 
statistically different.31  
Lardner R et al had published a randomized comparative study in 2008, comparing 
size 2 P-LMA and Classic LMA in paralysed, ventilated children. 51 children of 
weight 10 to 20 kg within ASA I, II were studied. The oro-pharyngel leak pressure 
for P-LMA (23.7cmH2O) was significantly higher than that of classic 
LMA(16.5cmH2O). Leak fraction values were similar for both devices. Fiberoptic 
view was better for P-LMA. Gastric insufflations was more common during leak 
determination in case of Classic LMA (12/26 Classic LMA and 2/25 P-LMA,p-
0.006).32 
Goldman K et al published a study in 2005, comparing size 2 Classic LMA and P-
LMA in 30 spontaneously breathing children of weight 10 to 21 kg. The variables in 
this randomized crossover study were insertion ease, initial airway quality,fiberoptic 
position, maximum tidal volume and airway-leak pressure. The authors had reported 
a significantly high maximum tidal volume and airway-leak for P-LMA (p value 
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0.001). The insertion ease and initial airway quality were observed to be similar. The 
authors concluded that the above mentioned advantages of P-LMA could have 
implications for using the device for positive pressure ventilation in children.33 
Shimbori Het al had published a study in 2004, in 60 patients belonging to ASA I, II 
of age 1-6 years and weight 10-20 kg, who underwent herniorrhaphy, myringotomy 
and orchidopexy. The authors had compared Classic LMA and P-LMA. They found 
the ease of insertion and airway-sealing pressure to be similar for the two LMAs. 
They also found no difference in the anatomical positions as determined by 
fiberoptic bronchoscopy.34 
Figueredo E et al  had  published a randomized study in 2003 between P-LMA and 
laryngeal tube by considering ease of insertion, hemodynamic changes and 
ventilation qualities in spontaneously breathing,anaesthetized,adult ASA I, II 
patients. They found first time insertion success rates were high with P-LMA (77% 
vs. 51%). Expired tidal volume and ability to achieve hands-free ventilation were 
high with P-LMA. They concluded that P-LMA showed greater ease of insertion and 
reliability than laryngeal tube.35 
Brimacombe J et al in 2002 published a multicenter study comparing P-LMA with 
classic LMA. They compared insertion success rate and time, efficacy of seal, 
fiberoptically determined anatomic position, oro-gastric tube success, intra operative 
and post operative complications. About 384 adult patients of ASA I, II was taken 
into study. Based on this study they concluded that insertion was easier in classic 
LMA and P-LMA formed better seal and allowed easier and quicker insertion of oro-
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gastric tube. Intra operative complications and postoperative sore throat were similar 
in both the groups.36 
Brimacombe J et al published ‘The Proseal Laryngeal Mask Airway’- a 
randomized, crossover study in 2000 with standard LMA in 60 adult paralysed 
patients and found P-LMA was capable of achieving a more effective seal than the 
LMA and facilitated gastric tube placement. At the same time, P-LMA was more 
difficult to insert unless an introducer tool was used.37 
Brain AIJ et al published in 2000 studied about Proseal LMA- a laryngeal mask 
with esophageal vent. Their crossover comparison with classic LMA in 30 adult 
female patients showed no difference in insertion, trauma or airway quality. At 60 
cms H2O intra cuff pressure, the P-LMA gave twice the sealing pressure of classic 
LMA. (p <0.0001) and permitted blind insertion of gastric tube in all cases.38 
Keller C et al in 1999, compared four tests for comparing airway sealing pressure 
with LMA-the audible noise, oral capnography, manometric stability and 
auscultation methods. They studied 80 anaesthetized, paralysed adult patients. They 
concluded manometric stability test had higher mean airway sealing pressure             
(p <0.0001) and better  inter-observer  reliability (p <0.0001) compared to other 
tests.39 
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ANATOMY OF UPPER AIRWAY 
PHARYNX: 
         The pharynx extends from posterior aspect of the nose at the base of the skull 
down to the level of lower border of cricoid cartilage where it becomes continuous 
with oesophagus, and the respiratory tract through larynx. The soft palate partially 
divides the pharynx into two, an upper nasopharyngeal portion and a lower 
oropharyngeal portion. Pharynx is partially divided by the soft palate into 
1) Nasopharynx,  
2) Oropharynx,  
3)  Laryngopharynx. 
1)Nasopharynx: 
This is upper part of pharynx situated behind the nose, and above the lower 
border of soft palate. The roof and posterior wall form a continuous slope, 
opposite the posterior part of body of sphenoid, basiocciput and anterior arch of 
atlas. Under the mucous membrane, opposite the basiocciput is a collection of 
lymphoid tissue called nasopharyngeal tonsil or adenoids. 
2)Oropharynx: 
         It is the middle part of pharynx, starts below the soft palate and extends to 
hyoid bone to continue as laryngopharynx at the level of upper border of the 
epiglottis.  
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Behind, it is supported by the body of the axis vertebra. In the lateral walls of 
oropharynx are situated the tonsillar pillars or fauces. The anterior pillar contains 
glossopharyngeal muscle and the posterior pillar contains palatoglossus muscle. 
3) Laryngopharynx: 
It is also called hypopharynx. It is situated behind the larynx. It extends from 
upper border of the epiglottis to lower border of the cricoid cartilage. The lateral 
wall presents a depression called piriform fossa, one on each side of the inlet of 
larynx. The fossa is bounded medially by aryepiglottic fold and laterally by 
thyroid cartilage and thyrohyoid membrane. Beneath the mucosa of the fossa, 
there lies the internal laryngeal nerve. Removal of the foreign bodies from the 
piriform fossa may damage this nerve. 
 
TONGUE: 
Tongue is a muscular organ situated in the floor of the mouth. It has an oral 
part that lies in the mouth and a pharyngeal part that lies in the pharynx. The oral and 
pharyngeal parts are separated by a V shaped sulcus, the sulcus terminalis. 
Oral part:Placed on the floor of the mouth. The margins are free and in contact with 
gums and teeth. 
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Pharyngeal part:The posterior part of the tongue is connected to epiglottis by folds 
of mucous membrane. These are median glossoepiglottic fold and the right and left 
glossoepiglottic folds. On either side of the median fold there is a pouch called 
vallecula. The lateral folds separate the vallecula from piriform fossa. 
 
Figure 1.Anatomy of upper airway. 
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SUPRAGLOTTIC AIRWAY DEVICES: 
          Supraglottic devices have been widely used as an alternative to tracheal 
intubation during general anaesthesia. Supraglottic airway devices have become a 
standard fixture in airway management, filling a niche between the face mask and 
tracheal tube in terms of both anatomical position and degree of invasiveness. They 
are easily inserted, better tolerated with lesser hemodynamic changes, have 
favourable respiratory mechanics and decreased airway morbidity. These devices sit 
outside the trachea but provide a hands-free means of achieving a gas-tight airway. 
I-GEL:  
 
Figure 2.I gel - full view. 
DESCRIPTION OF I-GEL 
 I-gel (Intersurgical Ltd.., Wokingham, Berkshire, UK) is a single use, 
supraglottic airway management device. I-gel is made up of medical grade 
thermoplastic elastomer, which is soft, gel like, transparent and designed to 
anatomically fit the pharyngeal, laryngeal and perilaryngeal structures without an 
inflatable cuff because of its non-inflatable seal; I-gel has minimal risk of tissue 
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compression. Design of I-gel makes it an anatomical device as the distal soft non-
inflatable cuff achieves a mirrored impression of the pharyngeal, laryngeal and 
perilaryngeal structures and thus positions itself over laryngeal framework providing 
a reliable perilaryngeal seal. The tip of the distal non inflatable cuff lies in the 
proximal opening of esophagus, isolating the esophageal opening from the laryngeal 
inlet. Since the distal tip of the device fits snugly and anatomically correctly into the 
upper esophageal opening, the distal opening of the gastric channel allows for the 
passing of a nasogastric tube to empty the stomach contents and can facilitate the 
venting of gas from the stomach. 
 The proximal end of the cuff has an epiglottic rest with a ridge. The rest 
prevents the epiglottis from down folding whereas the ridge is in contact with the 
base of the tongue preventing the upward and outward movement of the I-gel. It 
consists of elliptical buccal cavity stabilizer which incorporates a circular airway 
lumen and a lumen for gastric tube insertion. The gastric channel runs through the 
device from its proximal opening at the side of the flat connector wing to the distal 
tip of the non-inflatable cuff. Size1 I-gel does not have a gastric lumen. The elliptical 
shape provides vertical stability and axial strength after insertion. It also has a built-
in bite block incorporated within the tube. There is a horizontal line in the integrated 
bite block (in size3, 4 and 5) which is a guide for correct depth of insertion. If 
correctly inserted it should coincide with the patient's teeth. The paediatric sizes 
don't have the horizontal line due to greater variability in the length of the Oro-
pharyngeal-laryngeal arch in children. It is latex free supraglottic device. Device 
selection is usually done on patient weight basis. 
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Table 1. I gel - different sizes and recommended corresponding patient weight (in 
kilograms). 
  
 
Figure 3. Parts of I - gel. 
 
I-GEL 
SIZE 
PATIENT SIZE PATIENT 
WEIGHT (Kg) 
I-GEL COLOUR 
1 NEONATE 2-5 PINK 
1.5 INFANT 5-12 BLUE 
2 SMALL PEDIATRIC 10-25 GREY 
2.5 LARGE PEDIATRIC 25-35 WHITE 
3 SMALL ADULT 30-60 YELLOW 
4 MEDIUM ADULT 50-90 GREEN 
5 LARGE ADULT > 90 ORANGE 
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Figure 4. View of the I-gel cuff in relation to the laryngeal framework. 1.Tongue, 
2.Base of tongue, 3.Epiglottis, 4.Aryepiglottic folds, 5.Pyriform fossa, 
6.Posterior cartilages, 7.Thyroid cartilage ,8.Cricoid cartilage, and 
9.Upper esophageal opening. 
 The firmness of the tube section and its natural Oro-pharyngeal curvature 
allows the device to be inserted by grasping the proximal end of I-gel and helps to 
glide the leading edge against the hard palate into the pharynx. It is not necessary to 
insert the fingers into the mouth of the patient for full insertion. The innovative 
15mm connector serves a number of functions- To provide a standard 15mm 
connection to the anaesthetic system or patient connection, provide an integral bite 
block, reduces the possibility of the airway channel, as a guide to correct positioning 
– the integral part of the bite-block is marked with a horizontally placed black line, 
which signifies the optimum position of the teeth while the device is in situ (not 
applicable to the paediatric sizes).  
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PRE-USE CHECKS: 
• Inspecting the device carefully, checking the airway patency and confirmation 
that there are no foreign bodies or a bolus of lubricant obstructing the distal 
opening of the airway or gastric channel. 
• Careful inspection of the device, ensuring surfaces are smooth and intact and 
also that the gastric channel is patent. 
• Discarding the device if the airway tube or the body of the device looks 
abnormal or deformed. 
• Checking if the 15mm connector fits the patient connection. 
 
INSERTION TECHNIQUE: 
 An appropriate size of I-gel has to be chosen and prepared prior to insertion. 
The I-gel is supplied in a protective cradle or cage pack to ensure the device is 
retained in the correct flexion prior to use and also acts as a base for lubrication. The 
I-gel must always be separated from the cradle or cage pack prior to insertion. A 
smaller and larger size of the I-gel should be readily available. Adequate preparation, 
proper lubrication of the device and correct positioning of the head and neck with 
optimum mouth opening is the key to a successful insertion of I-gel.  Pre-
oxygenation is ensured before insertion of device. 
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STEPS FOR INSERTION: 
1. I-gel should be lubricated on the posterior aspect of distal non inflatable cuff 
and firmly grasped along the integral bite block. The device is positioned so that 
the I-gel cuff outlet is facing towards the chin of the patient. 
2. The patient should be placed in the ‘sniffing the morning air’ position with head 
extended and neck flexed. The chin should be gently pressed down before 
proceeding to insert the I-gel. 
3. The leading soft tip is introduced into the mouth of the patient in a direction 
towards the hard palate. 
4. I-gel is glided downwards and backwards along the hard palate with a 
continuous but gentle push until a definitive resistance is felt.  
5. It is not necessary to insert fingers or thumbs into the patient’s mouth during the 
process of inserting the device. If there is early resistance during insertion, a 
‘jaw thrust’, ‘Insertion with deep rotation’ or triple manoeuvre is done.  
6. If this does not solve the problem, a smaller size of I-gel is tried. 
7. At this point the tip of the airway should be located into the upper esophageal 
opening and the cuff should be located against the laryngeal framework. The 
incisors should be resting on the integral bite-block. 
8. I-gel should be taped down from ‘maxilla to maxilla’. If required, an appropriate 
size nasogastric tube may be passed down the gastric channel. 
9. The device is then connected to the breathing apparatus. 
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REMOVAL OF THE DEVICE: 
1. The device is removed once consciousness is regained and the protective 
reflexes are present, after suction of the oral cavity and pharynx. 
2. I-gel can be removed when the patient is awake and easily arousable with verbal 
commands. 
 
 
. 
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PROSEAL LARYNGEAL MASK AIRWAY 
DESCRIPTION OF PROSEAL LMA: 
 The proseal LMA (P-LMA) was introduced by Dr.Archie Brain in 2000 
(Intavent Orthofix, Maidenhead, UK).  
 It has four main parts: the cuff, inflation line with pilot balloon, airway tube, 
and drain (gastric access) tube. All components are made from silicone and are latex-
free. It is available in six sizes 
 
 
. 
 
 
 
 
 
Figure 5. Proseal- LMA - full view. 
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Table 2.Characteristics of P-LMA of different sizes. 
 
 
Size Patient 
weight 
Max. Cuff 
inflation(ml) 
Max. 
Gastric tube 
size(Fr) 
Max. 
Fiberscope 
size(mm) 
Drain tube 
length(cm) 
ETT 
uncuffed 
(ID in mm) 
1.5 5-10 7 10 - 18.2 4.0 
2 10-20 10 10 - 19.0 4.0 
2.5 20-30 14 14 - 23.0 4.5 
3 30-50 20 16 - 26.5 5.0 
4 50-70 30 16 4 27.5 5.0 
5 70-100 40 18 5 28.5 6.0cuffed 
 
  
 The airway tube of the proseal LMA is shorter and smaller in diameter than 
that of the LMA-Classic and is wire reinforced, which makes it more flexible. There 
is a locating strap on the anterior distal tube to prevent the finger slipping off the 
tube and to provide an insertion slot for the introducer tool. An accessory vent under 
the drainage tube in the bowl prevents secretions from pooling and acts as an 
accessory ventilation port. The proseal LMA has a deeper bowl than the LMA-
Classic and does not have aperture bars. There is a bite block between the tubing at 
the level where the teeth would contact the device.  
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Figure 6.Parts of proseal LMA. 
 
 
26 | P a g e  
 
The drain tube is parallel and lateral to the airway tube until it enters the cuff 
bowl, where it continues to an opening in the tip that is sloped anteriorly. When the 
proseal LMA is correctly positioned, the cuff tip lies behind the cricoid cartilage at 
the origin of the esophagus. It allows liquids and gases to escape from the stomach, 
reduces the risks of gastric insufflation and pulmonary aspiration, allows devices to 
pass into the esophagus, and provides information about the proseal LMA position. 
The drain tube is designed to prevent the epiglottis from occluding the airway tube, 
eliminating the need for airway bars. A gastric tube can be passed into the esophagus 
through the drainage port. A plastic supporting ring around the distal drain tube 
prevents the tube from collapsing when the cuff is inflated. 
The proseal LMA has a second dorsal cuff. This pushes the mask anteriorly 
to provide a better seal around the glottic aperture and helps to anchor the device in 
place.  The dorsal cuff is not present on sizes 1.5, 2 and 2.5. The ventral cuff is larger 
proximally to improve the seal. 
 A silicone-coated malleable metal introducer to facilitate placement of the 
proseal LMA is available. It has a curved, malleable silicone-coated blade with a 
guiding handle. The distal end fits into the locating strap, and the proximal end fits 
into the airway tube. 
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INSERTION TECHNIQUES: 
1) FINGER  INSERTION TECHNIQUE: 
 The patient is positioned as for regular laryngoscopy, with neck flexion and 
head extension. The cuff is deflated fully and posterior part is lubricated with 
water based gel. The device is held like a pen, index finger is at the point where 
the mask joins the tube. After opening the mouth, insertion is done along the 
midline with the help of the longitudinal black line on the LMA, with the device 
pressing on the hard palate. The index finger moves in a cranioposterior direction. 
Resistance is felt on reaching the upper esophageal sphincter. The non dominant  
 
hand helps in widening the cranio-pharyngeal angle to aid insertion and during 
removal of the index finger from the mouth. The mask is inflated via the pilot 
balloon to a pressure not more than 60 cmH2O. A bite block is inserted and should 
remain in place until the LMA is removed, in order to reduce the possibility of 
biting and obstruction of the airway or damage to the tube. 
 
 
Figure 7. P-LMA held with index finger in the strap. 
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Figure 8. P-LMA - Wrist flexed with index finger in the strap. 
 
 
Figure 9. P-LMA - Mask slid inward, sliding the index finger. 
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Figure 10. P-LMA- Advancing into hypopharynx till resistance is felt. 
 
 
2) INTRODUCER METHOD: 
 Instead of the index finger, a metal introducer is used. The metal introducer is 
fit onto the device at the retaining strap found at the end of the cuff. The airway 
and drain tubes are folded over the convex part of the introducer. Along the 
curvature of the introducer, in one smooth sweeping motion the P-LMA is 
inserted till resistance of upper oesophageal sphincter is felt. 
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Figure 11.P-LMA - Tip of Introducer placed into strap. 
 
Figure 12. P-LMA -Tubes are folded around introducer. 
 
 
Figure 13. LMA proseal mounted on introducer. 
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Figure 14. P-LMA - Tip of cuff pressed against hard palate. 
 
 
Figure 15.Pressing the cuff of P-LMA against hard palate. 
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Figure 16.Advancing P-LMA into hypopharynx until resistance is felt. 
 
 
 
Figure 17.Holding the tubes of P-LMA while removing introducer. 
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3) GUM ELASTIC BOUGIE GUIDED METHOD: 
  The bougie is inserted blindly or with laryngoscopy, into the esophagus. 
Then the drain tube is railroaded over the bougie. 
CUFF INFLATION: 
 
Figure 18. Cuff inflation of P-LMA. 
 
 After the proseal LMA has been inserted, the cuff should be inflated with 
enough air to achieve an intracuff pressure of up to 60 cm H2O. During insertion and 
cuff inflation, the front of the neck should be observed to see if the cricoid cartilage 
moves forward, indicating that the mask has correctly passed behind it.  
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CONFIRMATION AFTER PLACEMENT:  
1. A small amount (1 to 2 ml) of water-based gel or soap bubble is placed on the end 
of the drainage tube that protrudes from the mouth and positive pressure applied 
to the airway tube. If the proseal LMA is properly placed, there should be a slight 
up/down movement of the lubricant. The soap bubble may move when the 
lubricant gel does not. If there is no movement or the bolus is ejected, the mask 
may not be correctly placed. 
2. The drainage tube should be tested for patency. This can be done by passing a 
gastric tube, a flexible endoscope, or a lighted stylet through the drainage tube. 
Easy passage indicates correct positioning; difficulty suggests that the mask 
should be repositioned, even if ventilation is satisfactory. 
3. The suprasternal notch tap test involves tapping the suprasternal notch or cricoid 
cartilage and observing simultaneous movement of the soap bubble at the 
proximal end of the drainage tube. However, this can produce both false positive 
and false negative results. 
4. Proper proseal LMA positioning can also be detected by inserting a lighted stylet. 
If the tip is folded over, the stylet will meet resistance 1 to 2 cm from the tip of 
the drain tube. 
  
35 | P a g e  
 
INSERTION PROBLEMS: 
The complications include; 
• Laryngospasm, bronchospasm, 
• Trauma to the airway, 
• Regurgitation and aspiration, 
• Malfunction of cuff, and 
• Malposition may be due to folding over of tip, tip of drain tube over the glottis 
opening or insufficient depth of insertion. 
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MATERIALS AND METHODS 
 
STUDY CENTRE:  This study “COMPARISON OF CLINICAL PERFORMANCE 
OF TWO SUPRAGLOTTIC AIRWAY DEVICES, I-GEL WITH PROSEAL - 
LARYNGEAL MASK AIRWAY (LMA) IN PATIENTS UNDERGOING 
ELECTIVE SURGERIES – A PROSPECTIVE RANDOMIZED STUDY ” was 
conducted in Department of Anaesthesiology, Thanjavur  medical college, 
Thanjavur.  
 
STUDY POPULATION: After approval from the Ethical Committee, informed 
consent was obtained from seventy patients (American Society of Anesthesiologists 
physical status-ASA grade  I and  II ) scheduled for puerperal/laparoscopic 
sterilisation under general anaesthesia, after explaining about the supraglottic airway 
devices. 
  
STUDY DESIGN: This was a Prospective, Randomized, Single Blinded (to the 
patient) study. 
 
SAMPLE SIZE CALCULATION: 
Based on the following formula, 
2 (Zα + Zβ) 2 σ2 
∆2 
 
 
   n =   
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 Where, 
 Zα was the standard normal value (95% confidence interval) = 1.96. 
 Zβ was the power of the test (80%) = 0.84. 
 Mean insertion time for I gel = 11.12 secs. 
Mean insertion time for proseal LMA = 15.13 secs.22 
 σ   was the standard deviation = 2.42. 
 ∆ = mean difference/effect size. 
     = 4.01 / 2.42 
     = 1.65 
 By applying these values, the sample size was 70 (35 in each group). 
 
PERIOD OF STUDY:  August 2015 to October 2017. 
 
INCLUSION CRITERIA: 
1. Adult patients of aged between 20 and 35yrs, 
2. ASA grade I and II,  
3. Patients undergoing puerperal/laparoscopic sterilization. 
4.Mallampatti grade 1 and 2 
 
EXCLUSION CRITERIA: 
1. Patients with mouth opening less than 2.5 cms, 
2. Patients with risk of aspiration such as full stomach, hiatus hernia, 
gastro esophageal reflux disease,  
3. Upper respiratory tract infection/sore throat, 
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4. Patients with abnormal or distorted anatomy of pharynx 
5. ASA grade III and IV, 
6. BMI>30, 
7. Mallampatti grade 3 and 4, 
8. Cervical spine disease, 
 
METHODOLOGY: 
The 70 patients were assigned to the device (I-gel and P-LMA) randomly by 
using a block of 10 random permutations of numbers 0 to 9. For block of 10 patients, 
I-gel was assigned for digits 0-4 and P-LMA for digits 5-9. Totally 7 blocks of 10 
random permutations of numbers were used to allot randomly 35 patients for each 
group.  
  
 Patients under this study were randomized to one of the two groups, with 35 
patients in each group. 
 Group A: I-GEL (N = 35) 
 Group B: PROSEAL LARYNGEAL MASK AIRWAY (N = 35). 
  
 Pre-anaesthetic evaluation was done on the day before surgery. It included 
general condition of the patient, airway assessment, nutritional status and body 
weight of the patient and detailed examination and assessment of cardiovascular and 
respiratory system. 
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 All patients were pre-medicated with Tablet Alprazolam 0.5mg and Tablet 
Ranitidine 150 mg on the night before the day of surgery. All patients were kept nil 
per oral 6 hours for solids and 2 hours for clear fluids prior to surgery.  
  
On arrival to operation theatre, an 18 Gauge intravenous cannula was placed 
into the largest vein on the dorsum of hand and attached to a normal saline infusion. 
  
All the drugs were maintained at adequate temperature and used within 15 
minutes of preparation. The patient's head was placed on a pillow of 10 cms with 
neck flexed and head extended. The patient was connected to a monitor , which 
recorded heart rate, non invasive blood pressure including systolic, diastolic and 
mean arterial pressures, continuous ECG monitoring and oxygen saturation. The 
baseline values of all these parameters were recorded. 
  
 The standard pre-use test was performed. I-gel or proseal LMA was 
lubricated with water soluble jelly on the posterior surface and kept ready. I-gel was 
used in Group-A patients. Size of  I-gel was decided according to body weight of the 
patient (I-Gel size 3: body weight between 30 and 60 kgs, size 4: weight between 50 
and  90kgs). Proseal LMA was used in Group-B patients. Size of proseal LMA was  
decided according to body weight of the patient (proseal LMA size 3: weight  
between 30 and 50 kgs, size 4: weight between 50 and 70kgs).  
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 All patients were pre-oxygenated with 100% Oxygen for 3 minutes with 
facemask. Anaesthesia was induced with injection  Propofol 2-2.5mg/kg and 
Fentanyl 1.5 µg/kg. After checking for ventilation,neuromuscular blockade was 
achieved with Injection. Atracurium 0.5mg/kg. Anaesthetic depth was deepened with 
1% Sevoflurane in oxygen using bag and mask ventilation for 3 minutes after which 
patient was kept in ‘sniffing the morning air’ position and the allotted device of 
appropriate size, according to weight of the patient was inserted in midline against 
the hard palate and push down into hypopharynx till resistance was met. The cuff 
was inflated (if proseal-LMA was used) with recommended volume of air (20ml, 
30ml of air for sizes 3, 4 respectively).  The device was connected to breathing 
circuit(circle system) and patient was ventilated. Maintenance was achieved by 
Nitrous oxide and Oxygen in 2:1 ratio with 1% Sevoflurane and intermittent doses of 
intravenous - Atracurium 0.1mg/kg. 
 
          Insertion time was recorded by an independent observer and defined as time 
interval between picking up the device and securing an effective airway. 
 
 An effective airway was judged by bilateral symmetrical chest movements, a 
square wave capnography trace, lack of gastric insufflation and absence of leak. If an 
effective airway was not achieved, the device was removed and three attempts were 
taken before recording failure of insertion. If three attempts were unsuccessful either 
an alternative device would had been inserted or trachea would had been intubated.  
 
 
41 | P a g e  
 
The number of insertion attempts was recorded. The cuff of proseal LMA was  
inflated with air and maintained at a pressure of less than 60 cms of water with the 
help of hand held aneroid manometer. The tube was fixed by taping over chin. 
  
The airway sealing pressure was determined by closing the expiratory valve 
of the circle system at a fixed gas flow of 3 litres per minute and recording the 
airway pressure at which equilibrium was achieved. At this time, gas leakage was 
determined at the mouth by the audible leak or by detection of an audible noise using 
a stethoscope placed just lateral to thyroid cartilage. 
  
 A lubricated gastric tube of appropriate size was placed into the stomach 
through the gastric channel. The ease of placement of gastric tube was recorded and 
its correct placement was confirmed by injection of air and epigastric auscultation or 
aspiration of gastric contents. Failure of gastric tube placement was also recorded 
and defined as failure to advance the gastric tube into the stomach within two 
attempts. 
 
 Intra-operative heart rate (HR) in beats per minute, non-invasive blood 
pressure (NIBP) in mm of Hg and oxygen saturation (SpO2) in percentage was 
recorded at 1 minute ,5 minutes, 10 minutes and 15 minutes after insertion of device. 
 
 At the end of surgical procedure anaesthesia was discontinued, patient was 
reversed with standard doses of injection neostigmine 0.05mg/kg with glycopyrollate 
0.01mg/kg intravenously and once the patient was awake, responsive and met all the 
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reliable signs of recovery from neuromuscular blockade, the device was removed. 
Post extubation cough, laryngospasm, blood staining of the device and tongue, lip 
and dental trauma were recorded. Regurgitation of gastric contents was also assessed. 
Post operative sore throat was assessed in post-anaesthesia care unit.  
 
STATISTICAL METHODS: 
 For continuous variables following normal distribution, it was expressed as 
mean ± standard deviation otherwise median (Inter-quartile range). Categorical 
variables were expressed as either percentages or proportions. Comparison of 
continuous variables was done by independent sample‘t’test. Comparison of 
categorical variables was done by Chi square test or Fisher's exact test based on the 
number of observations. 
 
  All the data was entered in MS-Excel spread sheet. Analysis was carried out 
by SPSS V16.0. All the p values < 0.05 was considered as statistically significant. 
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OBSERVATION AND RESULTS 
DEMOGRAPHIC VARIABLES: 
AGE DISTRIBUTION: 
Table 3. Mean age distribution (in years). 
 
 Mean Age N SD 
I-GEL 28.89 35 1.676 
P-LMA 28.80 35 1.952 
Total 28.84 70 1.807 
                              p value = 0.844(not significant). 
The mean age of patients in the groups I-gel and P-LMA were 
(28.89±1.676) and (28.80± 1.952) respectively. This data was statistically 
insignificant as the p value was >0.05. Thus, both the groups were comparable. 
 
 
Chart 1. Mean age distribution (in years). 
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WEIGHT DISTRIBUTION : 
 
Table 4.Mean weight distribution (in kgs). 
 
 
N Mean SD p value 
 
Weight 
I-GEL 35 58.51 5.549 
0.005 
P-LMA 35 53.51 8.480 
                       p value = 0.005 (significant) 
 
        The mean weight of patients in both the groups was statistically significant with 
a  p value <0.05. 
 
 
 
Chart 2. Mean weight distribution (in kgs) 
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ASA PHYSICAL STATUS DISTRIBUTION: 
 
Table 5.ASA physical status distribution. 
 
 
 
ASA 
Total 1 2 
 
 
Device 
I-GEL Count 33 2 35 
% within Device 94.3% 5.7% 100.0% 
P-LMA Count 32 3 35 
% within Device 91.4% 8.6% 100.0% 
       p value = 1.000 (not significant). 
 
The ASA physical status distribution in both the groups were comparable as 
the p value was >0.05, which is not significant. 
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Chart 3. ASA grade in I-gel 
 
 
 
 
Chart 4. ASA grade in P-LMA 
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INSERTION TIME (in seconds): 
 
Table 6. Mean insertion time for the device (in seconds). 
 
 
N Mean SD 
 
Insertion time 
I-GEL 35 12.40 1.063 
P-LMA 35 14.23 1.352 
                      p value=0.000(significant)                                                                                                             
 The mean insertion time of I-gel and P-LMA were (12.40± 1.063) and 
(14.23± 1.352) respectively. This data was statistically significant as the p value was 
<0.05. 
 
 
 
Chart 5. Mean insertion time (in seconds) 
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NUMBER OF ATTEMPTS TAKEN TO INSERT THE DEVICE: 
 
Table 7.Number of attempts taken to insert the device. 
 
 
  Number of 
attempts 
Total 1 2 
 
 
Device 
I-GEL Count 34 1 35 
% within Device 97.1% 2.9% 100.0% 
P-LMA Count 31 4 35 
% within Device 88.6% 11.4% 100.0% 
  p value = 0.356 (not significant). 
  
The number of attempts taken to insert the device in the groups I-gel and P-
LMA were comparable, as the p value was > 0.05, which was not significant. 
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Chart6.Number of attempts taken to insert I-gel. 
 
 
 
Chart7.Number of attempts taken to insert P-LMA. 
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AIRWAY SEALING PRESSURE DISTRIBUTION: 
 
Table 8.Airway sealing pressure distribution (in cms of  H2O). 
 
 Mean  N SD 
I GEL 23.40 35 1.063 
P-LMA 28.29 35 1.152 
Total 25.84 70 2.695 
     p value = 0.000 (significant). 
 
The mean age of patients in the groups I-gel and P-LMA were (23.40±1.063) 
and (28.29± 1.152) respectively. This data was statistically significant as the p value 
was <0.05.  
 
 
 
 Chart8.Mean airway sealing pressure( incms H2O) 
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NUMBER OF ATTEMPTS TAKEN FOR GASTRIC TUBE INSERTION: 
 
Table 9. Number of gastric tube attempts by both groups. 
 
 
 Number of 
attempts 
Total 1 2 
 
 
Device 
I-GEL Count 34 1 35 
% within Device 97.1% 2.9% 100.0% 
P-LMA Count 34 1 35 
% within Device    97.1% 2.9% 100.0% 
       p value = 1.00 ( not significant) 
 
The number of attempts taken to insert the device in the groups I-gel and  
P-LMA, was not significant as the p value was >0.05. 
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HEMODYNAMIC CHANGES: 
 
HEART RATE: 
 
Table 10. Intergroup comparison of mean heart rate (bpm) changes in response to 
insertion of the device. 
 
 
 Device N Mean SD p value 
HR_basal I-GEL 35 77.57 5.265 
0.009 
P-LMA 35 82.51 9.410 
HR_1min I-GEL 35 82.06 6.444 
0.004 
P-LMA 35 87.37 8.342 
HR_ 5min I-GEL 35 81.71 6.551 
0.002 
P-LMA 35 86.03 8.463 
HR_10min I-GEL 35 79.09 6.736 
0.006 
P-LMA 35 84.06 7.829 
HR_15min I-GEL 35 77.40 6.869 
0.000 
P-LMA 35 83.80 7.231 
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Chart9.Intergroup comparison of mean heart rate (bpm) changes in response to  
 insertion of the device. 
 
 
Comparing the mean heart rate in both the groups at corresponding timings 
showed that there was a significant difference at baseline(p value=0.009),1 minute(p 
value=0.004), 5 minutes(p value=0.002), 10 minutes(p value=0.006)and 15 minutes 
(p value=0.000) after insertion of the device. (p <0.05 is significant).  
 
 
77.6
82.1 81.7
79.1
77.4
82.5
87.4
86.0
84.1 83.8
72.0
74.0
76.0
78.0
80.0
82.0
84.0
86.0
88.0
90.0
HR_Basal HR_1M HR_5M HR_10M HR _15M
I GEL PLMA
54 | P a g e  
 
 
 
SYSTOLIC BLOOD PRESSURE: 
 
Table 11. Intergroup comparison of mean systolic blood pressure (mm Hg) changes 
in response to insertion of the device. 
 
 
 
 
 
 
 
 
 
 Device N Mean SD p value 
SBP_basal I-GEL 35 124.34 7.300 
0.218 
P-LMA 35 122.34 6.111 
SBP_1min I-GEL 35 122.46 5.293 
0.081 
P-LMA 35 119.60 7.908 
SBP_5min I-GEL 35 118.09 6.767 
0.173 
P-LMA 35 115.71 7.606 
SBP_10min I-GEL 35 114,63 6.774 
0.540 
P-LMA 35 113.60 7.204 
SBP_15min I-GEL 35 114.29 5.629 
0.314 
P-LMA 35 112.71 7.226 
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Chart 10. Intergroup comparison of mean systolicblood pressure (mm Hg) changes 
in response to insertion of the device. 
 
 
Comparing the mean systolic blood pressure in both the groups at 
corresponding timings showed that there was no significant difference at baseline (p 
value=0.218),1 minute (p value=0.081), 5 minutes (p value=0.173), 10 minutes (p 
value=0.540) and 15 minutes (p value=0.314) after insertion of the device. (p <0.05 
is significant).  
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DIASTOLIC BLOOD PRESSURE: 
 
Table 12. Intergroup comparison of mean diastolic blood pressure (mm Hg) changes 
in response to insertion of the device.  
 
 
 
 
 
 
 
 
 
 
 Device N Mean SD p value 
DBP_basal I-GEL 35 74.83 7.622 
0.052 
P-LMA 35 77.71 3.938 
DBP_1min I-GEL 35 73.63 7.345 
0.041 
P-LMA 35 76.69 4.562 
DBP_5min I-GEL 35 71.89 6.850 
0.009 
P-LMA 35 75.60 4.519 
DBP_10min I-GEL 35 69.69 6.163 
0.000 
P-LMA 35 74.83 4.308 
DBP_15min I-GEL 35 69.51 5.607 
0.000 
P-LMA 35 74.17 4.436 
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Chart11. Intergroup comparison of mean diastolic blood pressure (mm Hg) changes 
in response to insertion of the device. 
 
 
Comparing the diastolic blood pressure in both the groups at corresponding 
timings showed that there was no significant difference at baseline as the p value = 
0.052 (p >0.05 is non significant). There was a significant difference in diastolic 
blood pressure changes between the two groups at 1 minute (p value=0.041), 5 
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after insertion of the device (p <0.05 is significant).  
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MEAN ARTERIAL BLOOD PRESSURE: 
 
Table 13.Intergroup comparison of mean arterial blood pressure (mm Hg) changes in 
response to insertion of the device. 
 
 
 
 
 
 
 
 
 
 
 
 
 Device N Mean SD p value 
MBP_basal I-GEL 35 91.31 6.168 
0.238 
P-LMA 35 92.77 3.797 
MBP_1min I-GEL 35 89.91 5.260 
0.376 
P-LMA 35 90.97 4.649 
MBP_5min I-GEL 35 87.26 5.543 
0.165 
P-LMA 35 88.86 3.851 
MBP_10min I-GEL 35 84.71 5.108 
0.008 
P-LMA 35 87.77 4.285 
MBP_15min I-GEL 35 84.51 4.699 
0.024 
P-LMA 35 87.06 4.485 
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Chart 12. Intergroup comparison of mean arterial blood pressure (mm Hg) changes 
in response to insertion of the device. 
 
Comparing the mean arterial blood pressure in both the groups at 
corresponding timings showed that there was no significant difference at baseline (p 
value = 0.238) , at 1 minute (p value=0.376) and 3 minutes (p value=0.165) after 
insertion of the device (p value >0.05 non significant). There was a significant 
difference in mean arterial blood pressure changes between the two groups at 10 
minutes (p value=0.008) and at 15 minutes(p value=0.024) after insertion of the 
device (p<0.05 is  significant).  
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OXYGEN SATURATION (SpO2): 
 
Table 14. Intergroup comparison of oxygen saturation(%) changes in response to 
insertion of the device. 
 
 
 Device N Mean SD p value 
SpO2_basal I-GEL 35 100.00 0.000 
NA 
P-LMA 35 100.00 0.000 
SpO2_1min I-GEL 35 100.00 0.000 
NA 
P-LMA 35 100.00 0.000 
SpO2_5min I-GEL 35 100.00 0.000 
NA 
P-LMA 35 100.00 0.000 
SpO2_10min I-GEL 35 100.00 0.000 
NA 
P-LMA 35 100.00 0.000 
SpO2_15min I-GEL 35 100.00 0.000 
NA 
P-LMA 35 100.00 0.000 
*NA - Not Applicable. 
 
Comparing the oxygen saturation in both the groups at corresponding 
timings showed that the standard deviation of both the groups at baseline, 1 minute, 
5 minutes, 10minutes, 15 minutes after insertion of the device were zero, so the p 
value is not applicable. 
 
 
61 | P a g e  
 
 
POST EXTUBATION COUGH: 
Table 15. Intergroup comparison of post extubation cough in response to insertion of 
the device. 
 
 Post extubation cough 
Total Yes No 
 
 
 
Device 
I-GEL Count 0 35 35 
% within Device 0%        100.0% 100.0% 
P-LMA Count 0 35 35 
% within Device 0% 100.0% 100.0% 
 
Post extubation cough was not noted in any of the patient in both I-gel group and P-
LMA groups. 
 
LARYNGOSPASM: 
 
Table 16.Intergroup comparison of laryngospasm in response to insertion of the 
device. 
 
Laryngospasm was not noted in any of the patient in both I-gel and P-LMA groups. 
 Laryngospasm 
Total Yes No 
 
 
Device 
I-GEL Count 0 35 35 
% within Device 0% 100.0% 100.0% 
P-LMA Count 0 35 35 
% within Device 0%    100.0% 100.0% 
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NAUSEA / VOMITING: 
 
Table 17.Intergroup comparison of nausea / vomiting in response to insertion of the 
device. 
 
Nausea / vomiting was not noted in any of the patient in both I-gel and P-LMA 
groups. 
 
TRAUMA TO LIP / TEETH / PHARYNX: 
 
Table 18.Intergroup comparison of trauma to lip / teeth / pharynx in response to 
insertion of the device. 
Trauma to lip / teeth / pharynx was not noted in any of the patient in both I-gel and 
P-LMA groups. 
 
 Nausea / Vomiting 
Total Yes No 
 
 
Device 
I-GEL Count 0 35 35 
% within Device 0% 100.0% 100.0% 
P-LMA Count 0 35 35 
% within Device 0%    100.0% 100.0% 
 Nausea / Vomiting 
Total Yes No 
 
 
Device 
I-GEL Count 0 35 35 
% within Device 0% 100.0% 100.0% 
P-LMA Count 0 35 35 
% within Device 0%    100.0% 100.0% 
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POST OPERATIVE SORE THROAT : 
 
Table 19.Intergroup comparison of postoperative sore throat in response to insertion 
of the device. 
p value = 1.000 
 
 
 
Chart13.Intergroup comparison of postoperative sore throat in response to insertion 
of the device. 
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%
YES NO
 Sore throat 
Total Yes No 
 
 
Device 
I-GEL Count 1 34 35 
% within Device 2.9% 97.1% 100.0% 
P-LMA Count 2 33 35 
% within Device     5.7% 94.3% 100.0% 
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Post operative sore throat was noted in 1 patient in I-gel group out of 35 and 
in 2 patients of P-LMA group out of 35.  However the incidence was not statistically 
significant as p value was 1.000 (p value >0.05 non significant). The sore throat in all 
the cases were mild requiring no treatment.  
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DISCUSSION 
Safe and efficacious airway management is one of the most important aspects 
of anaesthesia. Securing an airway and ventilation is a basic part of the management 
of all patients, regardless of whether the patient requires a short duration or day care 
surgery. Today, the LMA has come to be widely used as an alternative airway device 
during day care anaesthesia. The LMA has become an alternative to the facemask, as 
well as to endotracheal tube. 
In this study, the safety and efficacy of the two supraglottic airway devices, 
namely, I-gel and proseal LMA had been compared. Seventy patients, scheduled for 
puerperal/laparoscopic sterilisation under general anaesthesia belonging to ASA 
class I and II were included in the study and were randomly divided into two groups 
with 35 patients in each group. In Group A (n=35), I-gel supraglottic airway device 
was used and in Group B (n=35) proseal laryngeal mask airway was used.  
The I-gel and P-LMA both had drain tubes which permitted passage of a 
gastric tube and allowed the gastric contents to drain to the exterior. The  I-gel does 
not have an inflatable cuff thereby avoiding the problems associated such as, 
increased cuff pressure above the recommended 60cm water either due to inflation 
with too much air or due to diffusion of nitrous oxide during the course of 
anaesthesia. The inflatable cuff also has the chances of malposition or get damaged 
after multiple uses, but before the recommended number of uses.   
Both the devices were compared in relation to the time taken for insertion of 
device, number of insertion attempts, airway sealing pressure, ease of gastric tube 
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placement, hemodynamic changes after insertion, intraoperative and postoperative 
complications. 
In our study, the mean time taken for insertion of I-gel was 12.40secs, which 
was shorter compared to P-LMA (mean insertion time for P-LMA was 14.23secs). 
This difference was statistically significant (p value = 0.000). This shorter time to 
insert could be attributed to the absence of an inflatable cuff in I-gel. This 
observation was similar to the results of Gurudas K et al20, Anjan D et al21, Gaurav C 
et al22, Hayashi K et al24 in their studies. 
In our study, I-gel was inserted in first attempt in 97.1% of patients and in 
second attempt in 2.9% of patients whereas, P-LMA was inserted in first attempt 
only in 88.6% of patients and in second attempt in 11.4% of the patients.In these 
patients jaw thrust maneuver was applied during the second attempt and the device 
was inserted. But the difference was not significant statistically (p value = 0.356). 
This observation was similar to the results of Sai S et al19 and Woo JJ et al28 in their 
studies. Brimacome J et al39 in his study had found insertion of P-LMA was difficult 
unless an introducer tool was used. Gasteiger L et al30, in his studies, found that 
insertion of both the devices were similarly easy using a guided technique. 
In our study, the mean airway sealing pressure of I-gel was 23.40 cmsH2O, 
which was lesser compared to P-LMA (mean airway sealing pressure for P-LMA 
was 28.29 cmsH2O). This difference was statistically significant (p value = 
0.000).This observation was similar to the results of Gaurav Cet al22, Singh I et al31 
in their studies.Gasteiger L et al25 in his study found similar oropharyngeal sealing 
pressures with both I-gel and P-LMA. On the contrary, I-gel was found to have 
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higher airway sealing pressure compared to P-LMA by SubroM etal26in his study, 
which was statistically significant. 
In our study, we found the passage of gastric tube with adequate lubrication 
through the drain tube of both I-gel and P-LMA to be easy. In both the groups, 
gastric tube was inserted in first attempt in 97.1% of patients and in second attempt 
in 2.9% of patients. But the difference was not significant statistically (p value 1.00). 
This observation was similar to the results of Sai S et al19, Gurudas K et al20 in their 
studies. On the contrary, Gaurav C et al22 had found gastric tube insertion to be easier 
in I-gel than P-LMA, which was statistically significant. 
In our study, we found the mean heart rate was found to be statistically 
significant in baseline, 1 minute, 5 minutes, 10 minutes and 15 minutes after 
insertion of the device (p value <0.05). We also found the changes in mean systolic 
blood pressure were not significant (p value > 0.05) in baseline, 1 minute, 5 minutes, 
10 minutes and 15 minutes after insertion of the devices, but changes in mean 
diastolic bloodpressure were significant (p < 0.05) at 1 minute, 5 minutes, 10 minutes 
and 15 minutes after insertion of the device except for mean diastolic blood pressure 
at baseline, where it was not significant ( p value > 0.05). We also found the changes 
in mean arterial blood pressure werenot significant (p value > 0.05) in baseline, 1 
minute and 5 minutes after insertion of the devices, but changes in mean systolic 
pressure were significant (p value < 0.05) 10 minutes and 15 minutes after insertion 
of the device. Also there was no change in oxygen saturation in both the groups from 
baseline till 15 minutes after insertion of the device.  
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Though hemodynamic changes with respect to heart rate, arterial pressures 
and oxygen saturation were statistically significant, the changes in absolute values in 
hemodynamics between these two groups were not clinically significant. During 
insertion of the device,pressor response may be produced by passage of the device 
through oral and pharyngeal spaces and the pressure produced by the device in 
pharyngeal and laryngeal spaces. Anjan D et al21 found that hemodynamics was 
lesser altered with I-gel than P-LMA, which were statistically significant.  
In our study, no incidence of complications like post extubation cough, 
laryngospasm, nausea / vomiting, trauma to lip / teeth / pharynx was noted. Post 
operative sore throat was noted in 2.9% of patients in I-gel group, whereas sore 
throat was noted in 5.7 % of patients in P-LMA group. Since the p value was 1.000, 
this difference was found to be not significant statistically.The sore throats in all the 
cases of both the groups were mild, requiring no treatment. Factors like multiple 
insertions of the device, the pressure exerted by the cuff against the pharyngeal 
mucosa, the cuff volumes and pressures could have contributed to the development 
of postoperative sore throat in both the groups. 
 The results of our study on the complications induced by the device, had been 
supported by other studies done by Sai S et al19, who showed that there was no 
significant complications in the first 12 hrs postoperatively and Singh I et al31,whose 
study showed that the incidences of airway trauma and blood staining were 
statistically insignificant. Gurudas K et al20 showed that the incidence of 
postoperative sore throat were insignificant in both the study groups. On the 
contrary, the study concluded by Gaurav C etal22 and Shi YB et al23 showed lesser 
complications with I-gel group than P-LMA group.  
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LIMITATIONS OF THE STUDY 
 
• Small sample size which consisted of adult population only. 
• Proper positioning of the supraglottic airway device was not confirmed with 
fiberoscope. 
• Cost effectiveness of the reusable against the single use device was not taken into 
consideration. 
• The Anaesthesiologist performing the insertion of the device could not be 
blinded. 
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SUMMARY 
 
A study entitled “COMPARISON OF CLINICAL PERFORMANCE OF 
TWO SUPRAGLOTTIC AIRWAY DEVICES, I-GEL WITH PROSEAL - 
LARYNGEAL MASK AIRWAY (LMA) IN PATIENTS UNDERGOING 
ELECTIVE SURGERIES – A PROSPECTIVE RANDOMIZED STUDY” was 
conducted in  department of Anaesthesiology, Thanjavur  medical college, 
Thanjavur. 
  
 After approval from the Ethics Committee, informed consent was obtained 
from 70 patients (ASA grade Iand II) scheduled for puerperal/laparoscopic 
sterilisation  under general anaesthesia. Patients under this study were randomized to 
one of the two groups, with 35 patients in each group. 
  
Group A: I-GEL (N = 35) 
 Group B: PROSEAL LARYNGEAL MASK AIRWAY (N = 35). 
  
 Pre-anaesthetic evaluation was done on the day before surgery. All patients 
were pre-medicated with Tablet Alprazolam 0.5mg and Tablet Ranitidine 150 mg on 
the night before the day of surgery. All patients were kept nil per oral 6 hours prior to 
surgery. On arrival to operation theatre, an 18 Gauge intravenous cannula was 
placed. The patient was connected to a monitor, which recorded heart rate, non 
invasive blood pressure including systolic, diastolic and mean arterial pressures, 
continuous ECG monitoring and oxygen saturation.  
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  All patients were pre-oxygenated with 100% Oxygen for 3 minutes 
with facemask. Anaesthesia was induced with injection Propofol 2-2.5mg/kg and 
Fentanyl 1.5 µg/kg. After checking for ventilation ,neuromuscular blockade was 
achieved with injection Atracurium 0.5mg/kg. Anaesthetic depth was deepened with 
1% Sevoflurane in oxygen using bag and mask ventilation for 3 minutes after which 
patient was kept in ‘sniffing the morning air’ position and the allotted device of 
appropriate size was inserted. The device was connected to breathing circuit and 
patient was ventilated through ventilator with appropriate settings. Maintenance was 
achieved by Nitrous oxide and Oxygen in 2:1 ratio with 1% Sevoflurane and 
intermittent doses of intravenous Atracurium 0.1mg/kg. 
 
 Insertion time was recorded by an independent observer and defined as time 
interval between picking up the device and securing an effective airway.An effective 
airway was judged by bilateral symmetrical chest movements, a square wave 
capnography trace, lack of gastric insufflation and absence of leak.. The number of 
insertion attempts was recorded. The cuff of proseal LMA was inflated with air and 
maintained at a pressure of less than 60 cms of water.. 
  
The airway sealing pressure was determined by closing the expiratory valve 
of the circle system at a fixed gas flow of 3 litres per minute and recording the 
airway pressure at which equilibrium was achieved. At this time, gas leakage was 
determined at the mouth by the audible leak or by detection of an audible noise using 
a stethoscope placed just lateral to thyroid cartilage. 
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 A lubricated gastric tube of appropriate size was placed into the stomach 
through the gastric channel. The ease of placement of gastric tube was recorded. 
  
 Intra-operative heart rate (HR) in beats per minute, non-invasive blood 
pressure (NIBP) in mm of Hg and oxygen saturation (SpO2) in percentage was 
recorded at 1 minute ,5 minutes, 10 minutes and 15 minutes after insertion of device. 
At the end of surgical procedure anaesthesia was discontinued, patient was reversed 
with standard doses of injection Neostigmine 0.05mg/kg with Glycopyrollate 
0.01mg/kg. Post extubation cough, laryngospasm, blood staining of the device and 
tongue, lip and dental trauma were recorded. Regurgitation of gastric contents was 
also assessed. Post operative sore throat was assessed in post-anaesthesia care unit.  
 
 
 
 
 
 
 
 
 
 
 
 
  
73 | P a g e  
 
 
Table 20.Overall comparison of both the groups based on the results obtained. 
 
 Group A (I-gel) Group B (P-LMA) 
Mean age (in years) 28.89 28.80 
Mean weight (in kgs) 58.51 53.51 
ASA physical status - I / II 33 / 2 32 / 3 
Mean time taken for insertion  
(in seconds) 
12.40 14.23 
Number of attempts taken for insertion 
of device - first / second 
34 / 1 31 / 4 
Airway sealing pressure (cms H2O) 23.40 28.29 
Number of attempts taken to insert 
gastric tube - first / second 
34 / 1 34 / 1 
Post extubation cough 0 0 
Laryngospasm 0 0 
Trauma to lip/teeth/pharynx 0 0 
Nausea/vomiting 0 0 
Postoperative sore throat  1 2 
 
 The mean time taken for insertion of the device was lower in I-gel group, 
compared to P-LMA, which was statistically significant (p value = 0.000). 
  
I-gel was successfully inserted in 34 patients in first attempt, whereas P-LMA 
was successful in 31 patients in first attempt. But this difference was not statistically 
significant (p value = 0.356). 
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The mean airway sealing pressure of I-gel was 23.40 cmsH2O, which was 
smaller compared to mean airway sealing pressure of P-LMA which was 28.29 
cmsH2O. This difference was statistically significant (p value = 0.000). 
 Gastric tube insertion was successful in first attempt in 34 patients of both      
I-gel  and P-LMA groups. But this difference was not statistically significant (p value 
= 1.00). 
The mean heart rate was found to be statistically significant in baseline, 1 
minute, 5 minutes, 10 minutes and 15 minutes after insertion of the device ( p value 
<0.05). We also found the changes in mean systolic blood pressure were not 
significant (p value > 0.05) in baseline, 1 minute, 5 minutes, 10 minutes and 15 
minutes after insertion of the devices, but changes in mean diastolic blood pressure 
were significant (p < 0.05) at 1 minute, 5 minutes, 10 minutes and 15 minutes after 
insertion of the device except for mean diastolic blood pressure at baseline, where it 
was not significant ( p value > 0.05). We also found the changes in mean arterial 
blood pressure were not significant (p value > 0.05) in baseline, 1 minute and 5 
minutes after insertion of the devices, but changes in mean systolic pressure were 
significant ( p value < 0.05 ) 10 minutes and 15 minutes after insertion of the device. 
Also there was no change in oxygen saturation in both the groups from baseline till 
15 minutes after insertion of the device.  
Though hemodynamic changes with respect to heart rate, arterial pressures 
and oxygen saturation were statistically significant, the changes in absolute values in 
hemodynamics between these two groups were not clinically significant. During 
insertion of the device, pressor response may be produced by passage of the device  
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through oral and pharyngeal spaces and the pressure produced by the device in 
pharyngeal and laryngeal spaces.  
In our study, no incidence of complications like post extubation cough, 
laryngospasm, nausea / vomiting, trauma to lip / teeth / pharynx was noted. Post 
operative sore throat was noted in 2.9% of patients in I-gel group, whereas sore 
throat was noted in 5.7 % of patients in P-LMA group. Since the p value was 1.000, 
this difference was found to be not significant statistically.The sore throats in all the 
cases of both the groups were mild, requiring no treatment. Factors like multiple 
insertions of the device, the pressure exerted by the cuff against the pharyngeal 
mucosa, the cuff volumes and pressures could have contributed to the development 
of postoperative sore throat in both the groups. 
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CONCLUSIONS 
 
 From this study we conclude that both I-gel and proseal LMA are safe and 
effective supraglottic airway devices, whereas I-gel is relatively easier and faster to 
insert with lesser hemodynamic changes compared to proseal LMA. Insertion is 
smooth without any trauma to anatomical structures in both I-gel and proseal LMA. 
Though I-gel produces lesser airway sealing pressure compared to proseal LMA, still 
I-gel is safer alternate airway device in positive pressure ventilation. The gastric 
access is easy and atraumatic, with majority being inserted in the first attempt in both 
the groups.Patients in both the groups were relatively free of postextubation cough, 
laryngospasm, nausea and vomiting and postoperative sore throat. 
 
 Both I-gel and proseal LMA are safe and patient friendly tools in the hands of 
anaesthetists for surgeries under general anaesthesia with positive pressure 
ventilation. 
  
 
 
  
77 | P a g e  
 
 
 
RECOMMENDATIONS 
 
1. I-gel is relatively easier and faster to insert compared to proseal LMA. 
2. I-gel is a safer alternate airway device in positive pressure ventilation compared 
to proseal LMA. 
3. Both I-gel and proseal LMA cause lesser intra operative and postoperative 
complications. 
4. Both I-gel and proseal LMA are better alternatives to endotracheal tube in 
patients undergoing general anaesthesia with positive pressure ventilation.  
5. Both I-gel and proseal LMA are safe and effective supraglottic airway       
devices. 
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     STUDY PROFORMA 
  
“COMPARISON OF CLINICAL PERFORMANCE OF TWO SUPRAGLOTTIC 
AIRWAY DEVICES, I-GEL WITH PROSEAL - LARYNGEAL MASK AIRWAY 
(LMA) IN PATIENTS UNDERGOING ELECTIVE SURGERIES – A 
PROSPECTIVE RANDOMIZED STUDY ”. 
     
  Group A: I-GEL (size:    ) 
  Group B: PROSEAL LMA  (size:    ) 
 
Name: 
Age/Gender: 
IP number/ Date of surgery: 
ASA physical status 
Weight: 
Height: 
Body Mass Index: 
Pre op examination: 
Pulse rate: 
Blood pressure: 
Cardiovascular system: 
Respiratory system: 
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Airway: 
Mouth opening (cms): 
 Mallampatti Grade: 
Neck movements: 
Duration of surgery: 
Investigations: 
Premedication: 
 
OBSERVATIONS: 
1) Insertion time: 
2)Ease of insertion: 
3) Number of device insertion attempts: 
One  
Two  
Three  
Failure  
 
4)Gastric tube access:     ( Yes  /   No) 
 
 
  
First attempt  
Second attempt  
85 | P a g e  
 
5)Airway sealing pressure: 
 
6)Intra-operative hemodynamics: 
 
            TIME 
 
HEART 
RATE 
               NIBP  
SpO2 
 
SBP 
 
DBP 
 
MAP 
Baseline      
1 min after insertion      
5 mins after insertion      
10mins after insertion      
15 mins after insertion      
 
 
7) Post-operative device related complications: 
 Post-extubationcough   yes / no 
 Laryngospasm    yes / no 
 Nausea/Vomiting   yes / no 
 Trauma to lip/teeth/pharynx  yes / no 
 Sore throat                                          yes / no 
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KEY TO MASTER CHART 
 
AI After insertion 
F Female 
kg Kilograms 
cm H2O Centimeter of water 
Y Yes 
N No 
min Minute 
 
Serial 
No. IP No.
Age 
(Years) Sex
Weight 
(Kg)
ASA 
grade Device Size
Insertion 
time 
(Seconds)
Number of 
device 
insertion 
attempts
Airway 
sealing 
pressure 
(cm H2O)
Number of 
gastric tube 
attempts
 HR Basal HR 1 min AI
HR 5 min 
AI
HR 10 
min AI
HR 15 
min AI
SBP 
Basal
SBP 1 
min AI
SBP 5 
min AI
SBP 10 
min AI
SBP 15 
min AI
1 400976
31 F 64 2 I GEL 4 13 1 23 1 81 85 78 68 70 120 120 118 118 120
2 400072
25 F 57 1 PLMA 4 13 1 29 1 68 75 78 76 75 126 120 118 116 114
3 400111
28 F 61 1 I GEL 4 12 1 22 1 64 70 82 85 83 124 122 114 110 118
4 399818
30 F 55 1 I GEL 3 12 1 23 1 82 90 92 84 86 120 116 110 106 108
5 399870
31 F 39 1 PLMA 3 14 1 28 1 87 96 95 98 95 124 120 123 124 126
6 400025
30 F 55 1 I GEL 3 11 1 25 1 82 90 92 86 84 118 116 112 108 108
7 400392
32 F 55 1 PLMA 4 13 1 30 1 96 99 96 94 90 130 120 118 116 112
8 400282
29 F 63 1 I GEL 4 13 1 24 1 82 84 80 82 80 128 130 128 124 122
9 400304
28 F 49 1 I GEL 3 10 1 23 1 79 84 84 76 70 117 121 122 118 120
10 400166
27 F 65 1 PLMA 4 14 2 28 2 74 79 72 73 77 118 104 100 101 103
11 400040
25 F 64 1 PLMA 4 15 2 29 1 78 86 85 88 86 117 120 118 115 112
12 400171
28 F 62 1 I GEL 4 12 1 22 1 76 80 82 79 76 120 118 113 110 108
13 400266
28 F 63 1 I GEL 4 13 1 24 1 80 78 74 74 72 132 127 126 126 120
14 400208
27 F 40 1 PLMA 3 14 1 27 1 76 85 90 88 91 128 134 128 125 120
15 400195
32 F 58 1 I GEL 3 13 1 23 1 78 90 88 93 90 136 126 120 112 122
16 400470
30 F 48 2 PLMA 3 13 1 27 1 90 92 90 88 86 112 114 108 108 109
17 400301
28 F 62 1 I GEL 4 13 1 22 1 78 82 85 84 83 108 110 104 104 106
18 400421
29 F 61 1 I GEL 4 14 1 23 1 78 86 84 83 85 108 112 104 104 106
19 399922
29 F 43 1 PLMA 3 14 1 28 1 76 85 88 89 85 110 110 100 108 112
20 400327
27 F 58 2 PLMA 4 20 2 29 1 67 73 69 72 71 117 126 120 115 106
21 399721
30 F 62 1 I GEL 4 12 1 23 1 72 74 78 82 80 122 120 112 108 120
22 399457
26 F 45 1 PLMA 3 13 1 28 1 101 103 99 96 94 129 120 122 123 130
23 400083
27 F 50 1 I GEL 3 12 1 22 1 76 85 87 86 84 120 118 112 108 110
MASTER CHART
